Evans concluded that, There is an urgent need for studies that accurately measure muscle mass, strength, and mobility during GLP-1 agonistinduced weight loss and regain of weight after they are stopped, especially in older people. October 28, 2024: FDA Issues Warning About Using Compounded Semaglutide Drugs for Weight Loss In October, the FDA issued a warning to patients who take compounded GLP-1 drugs for weight loss
Its mechanism is fundamentally different from blood-flow medications such as sildenafil and tadalafil
In fact, a study reported that 16.9-35.3% of IBS-D patients had been diagnosed with BAM (Slattery et al., 2015)
Iron supplementation to treat anemia in patients with chronic kidney disease
Dec 2022;47(12):2110-2116
In general, it is best to take most supplements with food as this is the way nature intended us to digest and absorb nutrients